The inaugural Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox. This edition includes:
The Mintz / Mergermarket Life Sciences M&A Report
Mintz partnered with Mergermarket to produce a comprehensive look at M&A activity in the Life Sciences sector, and the importance of corporate and cultural convergence in these transactions. The full report which consists of results from surveys of more than 100 senior-level US-based executives is available by registering here. You can also access the recording of the July 30 webinar about the report here. Below are a few insights from the report:
- M&A deals saw a slowdown in the first quarter of 2020 as compared to recent first quarters
- The lead driver for US companies participating in M&A deals was patent expiration
- In a substantial plurality of deals, the target/seller will continue operation as a standalone entity
- Integration planning and cultural due diligence are recommended to be a greater focus earlier in deal making
Download >> Life Sciences Newsletter - Inaugural Edition
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
